Site Search
Search Results
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
... for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it. There are significant disparities in health outcomes for Connecticut patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. “Expanding access to biomarker testing will help more people in Connecticut get the right treatment at the right time and avoid ...
Connecticut House Votes to Improve Access to Biomarker Testing
... for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it. There are significant disparities in health outcomes for Connecticut patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. “Expanding access to biomarker testing will help more people in Connecticut get the right treatment at the right time and avoid ...
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
... in who is benefiting from biomarker testing and biomarker-informed treatment. “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it,” said Bryte Johnson, ACS CAN Connecticut director of government relations. “There are significant disparities in health outcomes for Connecticut patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. Already, 20 states have passed similar laws to increase access to comprehensive biomarker testing—and it’s time for ...
Legislature Prioritizing Removing Barriers to Precision Treatments
... medicine treatments, is covered by Medicaid. Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. “Biomarker testing made a huge difference in my life,” said Erin Nielson, a ... my cancer’s DNA would not benefit from chemotherapy. In previous years, chemotherapy, surgery, and radiation would have been the standard of care for my type of cancer.” This legislation will help address a significant barrier and bring the promise of precision medicine to more people, ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality, affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer ...